Complete Genomics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Complete Genomics Inc's inventory turnover ratio, the ratio that measures Complete Genomics Inc's ability to manage its supply chain, sequentially decreased to 3.25 in the third quarter 2012, which does not come as a surprise, as the Complete Genomics Inc continue to experience headwinds, which also impact its supply chain. Complete Genomics Inc's average inventory processing period in the Sep 30 2012 quarter, has increased to 112 days, from 93 days, in the Jun 30 2012 quarter.

Within Healthcare sector 85 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the second quarter 2012, to 330.

GNOM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Complete Genomics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GNOM Inventory Turnover Ratio	(Sep 30 2012) III. Quarter	(Jun 30 2012) II. Quarter	(Mar 31 2012) I. Quarter	(Dec 31 2011) IV. Quarter	(Sep 30 2011) III. Quarter
Y / Y Inventory Growth	106.98 %	77.81 %	73.37 %	-	-
Y / Y Cost of Sales Growth	-11.66 %	32.67 %	-19.51 %	-	-
Inventory Turnover Ratio (TTM)	3.25	3.94	4.22	-	7.24
GNOM's Total Ranking	# 330	# 0	# 0	# 0	#
Average inventory processing period	112	93	86	-	50
Seq. Inventory Growth	-11.33 %	10.55 %	67.44 %	26.1 %	-23.82 %
Seq. Cost of Sales Growth	-11.01 %	53.3 %	-	-	33.65 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Laboratories Industry	# 7
Healthcare Sector	# 86
Overall Market	# 330

Inventory Turnover Ratio Statistics
High	Average	Low
3.94	3.6	3.25
(Jun 30 2012)		(Sep 30 2012)

GNOM Company Profile >> Back to GNOM Efficiency Comparisons >> Compare GNOM Inventory Turnover Ratio to its Competitors

Financial Statements
Complete Genomics Inc's Inventories	$ 7 Millions	Visit GNOM's Balance sheet
Complete Genomics Inc's Cost of Revenues TTM	$ 21 Millions	Visit GNOM's Income Statement
What are GNOM's Sales?		Visit GNOM's Sales by Segment

Other Inventory Turnover Ratios
Complete Genomics Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
GNOM's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for GNOM's Competitors
Inventory Turnover Ratio for GNOM's Suppliers
Inventory Turnover Ratio for GNOM's Customers

You may also want to know
GNOM's Sales Growth Rates	GNOM's Pe Price to earnings ratio	GNOM's Receivables Turnover Ratio	GNOM's Stock Quote
GNOM's Net Income Growth Rates	GNOM's Ps Price to Sales ratio	GNOM's Sales per Employee	GNOM's Asset Turnover Ratio
GNOM's Net Margin	GNOM's Pb Price to Book ratio	GNOM's Financial Strength Ratios	GNOM's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2012, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2012	Inventories at quarter ending Sep 30 2012
Inotiv Inc	8.20	$ 14.592 Millions	$ 2 Millions
Align Technology inc	8.16	$ 107.291 Millions	$ 13 Millions
Hill rom Holdings Inc	8.12	$ 879.600 Millions	$ 108 Millions
Antares Pharma Inc	7.92	$ 7.818 Millions	$ 1 Millions
Protalix Biotherapeutics inc	7.68	$ 6.966 Millions	$ 1 Millions
Patterson Companies Inc	7.42	$ 2,418.228 Millions	$ 326 Millions
Fonar Corporation	7.31	$ 21.667 Millions	$ 3 Millions
Ufp Technologies Inc	7.17	$ 69.474 Millions	$ 10 Millions
China Pediatric Pharmaceuticals, Inc.	7.17	$ 3.294 Millions	$ 0 Millions
Bioxytran Inc	6.95	$ 0.096 Millions	$ 0 Millions
Bohai Pharmaceuticals Group, Inc.	6.82	$ 25.093 Millions	$ 4 Millions
China Yct International Group, Inc.	6.61	$ 18.147 Millions	$ 3 Millions
Camp4 Therapeutics Corporation	6.59	$ 82.620 Millions	$ 13 Millions
Omnova Solutions Inc	6.59	$ 637.500 Millions	$ 97 Millions
Cocrystal Pharma Inc	6.43	$ 14.101 Millions	$ 2 Millions
Integrated Biopharma Inc	6.24	$ 30.139 Millions	$ 5 Millions
Perspective Therapeutics Inc	6.13	$ 3.220 Millions	$ 1 Millions
Adynxx, Inc.	6.11	$ 1.348 Millions	$ 0 Millions
Kewaunee Scientific Corporation	5.47	$ 65.201 Millions	$ 12 Millions
Cadence Pharmaceuticals Inc	5.34	$ 17.569 Millions	$ 3 Millions
Seelos Therapeutics inc	5.30	$ 1.746 Millions	$ 0 Millions
Steris Plc	5.21	$ 846.141 Millions	$ 162 Millions
Enzo Biochem Inc	5.08	$ 46.015 Millions	$ 9 Millions
Dexcom Inc	4.89	$ 37.602 Millions	$ 8 Millions
Nutrastar International Inc.	4.81	$ 5.810 Millions	$ 1 Millions
Intuitive Surgical Inc	4.80	$ 571.000 Millions	$ 119 Millions
Cantel Medical Corp	4.73	$ 222.965 Millions	$ 47 Millions
Henry Schein Inc	4.72	$ 4,687.511 Millions	$ 993 Millions
Lineage Cell Therapeutics Inc	4.65	$ 0.254 Millions	$ 0 Millions
Invacare Holdings Corporation	4.61	$ 974.380 Millions	$ 211 Millions

Date modified: 2026-09-08T15:07:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.